What are the side effects of taking Erdafitinib?

Erdafitinib (Erdafitinib), as a targeted therapy drug, can produce beneficial therapeutic effects on cancer, but it may also cause some side effects. It is important to note that the degree and specific manifestations of side effects vary from patient to patient. Some people may experience mild side effects, while others may feel them more pronounced. Here are some common side effects that may occur with erdafitinib:

1.Hypertension: Some patients may experience high blood pressure during use of erdafitinib. This is because the mechanism of action of erdafitinib may be related to some vascular tone.

2.Increased phosphate levels: Erdafitinib may cause increased phosphate levels in the body, which may require monitoring and management during treatment.

3.Fatigue: Some patients may experience fatigue or weakness. This is a relatively common side effect that may affect a patient's quality of life.

4.Hand-foot syndrome: Erdafitinib may cause hand-foot syndrome, which is characterized by redness, swelling, pain, or desquamation of the hands and feet. This may require timely processing and management.

5.Visual problems: Some patients may experience visual problems, including blurred or dry eyes. If you have such symptoms, you should inform your doctor promptly.

6.Nausea and Vomiting: Some patients may experience mild nausea and vomiting while taking erdafitinib. This can be relieved by taking medications or adjusting your diet.

7.Joint and muscle pain: Some patients may experience joint and muscle pain, which may be due to the effects of the drug on the body.

8.Rheumatic Reactions: Erdafitinib may cause rheumatism-like symptoms, including joint pain and swelling.

9.Electrocardiogram changes: The use of erdafitinib may cause electrocardiogram changes, so regular electrocardiogram monitoring may be required during treatment.

10.Abnormal liver function: Some patients may experience abnormal liver function while taking erdafitinib and require regular liver function tests.

11.Loss of appetite: Erdafitinib may cause loss of appetite in some patients, thereby affecting weight.

It is worth emphasizing that not every patient will experience the side effects listed above, and some side effects may be more obvious at the beginning of treatment and may lessen over time. It is very important for patients to maintain good communication with their doctors and promptly report any discomfort or concerns so that the doctor can make timely assessment and adjustments.

In addition, doctors may take a series of preventive and therapeutic measures to reduce the side effects that patients may experience while using erdafitinib. Overall, the management of side effects during treatment requires individualization and comprehensive consideration, and doctors will develop the most appropriate strategy based on the patient's specific situation. A professional physician should be consulted for the latest side effect information and advice.

Erdafitinib is not currently available in the country, so patients cannot purchase it domestically and need to purchase erdafitinib through foreign channels. The original drug of erdafitinib is mainly the Hong Kong version of the original drug, with a price of more than 20,000, and needs to be purchased through a Hong Kong pharmacy. The generic drugs are relatively cheaper, mainly the Laos version and the Bangladesh Yaopin International version, with a price of about 1,000 to 2,000, and the ingredients of the original drug and the generic drug are basically the same.